Pharmaceutical blockbusters
The significance of blockbusters in the pharmaceutical industry
Blockbusters generated cumulative revenues of $501 billion (over an average commercialization period of 6 years), representing 70% of total ...
Blockbuster Drug: What it is, How it Works - Investopedia
A blockbuster drug is an extremely popular drug that generates annual sales of at least $1 billion for the company that sells it.
What are pharma's next blockbusters? - PharmaVoice
According to Citeline, the most notable include: Lilly's newly approved GLP-1 agonist Zepbound ($2 billion forecast). Horizon's Tepezza, the ...
Best-selling pharmaceuticals of 2023: Metabolic drugs shine
In this list of best-selling pharmaceuticals in 2023, immunology and oncology lead the way. But the metabolic disease segment is surging.
Pharmaceutical blockbusters: the past, present, and future(?)
The industry as a whole relies on blockbusters - drugs with annual global revenues of $1 billion or more - to cover the flops and keep the entire enterprise ...
The top 20 drugs by worldwide sales in 2021 - Fierce Pharma
As the first lymphoma drug to hit the market in the BTK class in 2013, Imbruvica was an immediate success and achieved blockbuster status in its ...
Top pharmaceutical drugs - Statistics & Facts | Statista
The biggest: Humira and Lipitor · Performance on the largest market is essential · A new generation of blockbusters.
Pharma, don't abandon the blockbuster drug model just yet - ZS
There is no imminent risk of decline in the blockbuster model. In fact, it is thriving and acting as a salve for the industry against other pressures.
What Is a Blockbuster Drug? | The Motley Fool
A blockbuster drug is a medication that generates annual sales of over $1 billion. Weight-loss medications like Ozempic and Wegovy are among the latest drugs ...
Bye, bye blockbusters, hello niche busters - PMC
The so-called “blockbuster philosophy” that has dominated the pharmaceutical ... In 1996, blockbusters accounted for only 12% of drug sales. A decade later ...
Top 10 Blockbuster Drugs In 2021 - Nasdaq
In this article, we will walk you through the top 10 drugs based on this year's first nine months' data.
World's Bestselling Drugs Addicted to Broken U.S. Healthcare System
Blockbuster drugs, defined as therapeutic products generating at least $1 billion in annual revenue, are the key to outsized success for drug developers.
Thirteen potential blockbuster drugs to watch in 2024
Thirteen new-to-market therapeutics and drugs poised to launch in 2024 will achieve 'blockbuster' status by 2029 or deliver game-changing benefits to patients.
Big Pharma's most improved drugs: a new generation of blockbusters
These are the most improved products at each of the 10 largest pharma companies in the world by market capitalization over the course of a year.
What a $200 Billion Blockbuster Drug Reveals About Big Pharma's ...
AbbVie's success in navigating Humira's decline holds lessons for pharmaceutical companies, investors and policymakers.
Billion Dollar Blueprint: The Journey to Blockbuster Status | Evaluate
Discover how pharmaceutical companies achieve blockbuster drug success. Explore key strategies and insights from Citeline's Scrip team in this eBook.
What pharmacists should know about the blockbuster drugs this year
Blockbuster drugs are defined as highly sought-after pharmaceutical products that generate annual sales of at least $1 billion for the company that ...
... blockbuster drugs as new drugs that generated an annual revenue of more than $1 billion. To ensure that that only drugs were defined as blockbusters that ...
Blockbuster Drugs: The Rise and Fall of the Pharmaceutical Industry
Abstract. Most blockbusters have at least one thing in common—they are widely prescribed to treat a common illness, such as hypertension, high cholesterol, pain ...
Potential blockbuster drugs to watch in 2023
Lecanemab and the first potential gene therapy US launch for haemophilia A are two potential blockbuster Drugs to Watch™, says a 2023 ...